472 Anti-VEGF treatment amplifies immune checkpoint inhibitor induced immune responses by targeting B and regulatory T cells by Patrick Huang, Chi Ma, Tim F Greten, Firouzeh Korangy, Benjamin Ruf, William Telford, Mohamed-Reda Benmebarek, Cihan Oguz, Yuta Myojin, Matthias Seifert, Justin Lack, Kylynda Bauer, Marina Villamor Paya

Adenosine A2a receptor inhibition increases the anti-tumor efficacy of anti-PD1 treatment in murine hepatobiliary cancers by Yuta Myojin, Justin D. McCallen, Chi Ma, Kylynda C. Bauer, Benjamin Ruf, Mohamed-Reda Benmebarek, Benjamin L. Green, Simon Wabitsch, John C. McVey, Claude Fu, Changqing Xie, Tim F. Greten

Get full text

988 Vagal-CD8+ T cell neuroimmune axis modulates liver cancer by Chi Ma, Tim F Greten, Firouzeh Korangy, Benjamin L Green, Benjamin Ruf, Mohamed-Reda Benmebarek, Yuta Myojin, Jonathan Qi, Simon Wabitsch, Amran Nur, Kylynda C Bauer, Rajiv Trehan, Danielle Springer, Audrey Noguchi, Morteza Peiravi, Heather Potts

Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer by Stephen M Hewitt, David E Kleiner, Tim F Greten, William D Figg, Cecilia Monge, Seth M Steinberg, Maggie Cam, Benjamin Ruf, Austin G Duffy, Jonathan M Hernandez, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Bradford J Wood, Elliot B Levy, Israa Juburi, Bernadette Redd, Philip Homan

Get full text